Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

13.93 +0.06 (+0.43%)
Streaming Delayed Price Updated: 2:44 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 936,302
Open 13.86
Bid (Size) 13.93 (1,700)
Ask (Size) 13.94 (2,600)
Prev. Close 13.87
Today's Range 13.86 - 13.94
52wk Range 0.7830 - 25.00
Shares Outstanding 58,556,952
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm as there may be limited time to enforce your rights. 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+65.8%
+65.8%
1 Month
+49.1%
+49.1%
3 Month
+260.9%
+260.9%
6 Month
+339.4%
+339.4%
1 Year
+569.7%
+569.7%

More News

Read More
News headline image
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Halper Sadeh LLC Encourages ONTF, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation
Via MarketMinute
Topics Intellectual Property
News headline image
Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns ↗
Via MarketBeat
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc. (Nasdaq - VTYX), Flushing Financial Corp. (Nasdaq - FFIC), FONAR Corporation (Nasdaq -
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
Via MarketMinute
On Friday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗
Via Stocktwits
Topics ETFs Government Stocks
News headline image
Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗
Via Stocktwits
Topics Initial Public Offering
News headline image
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal ↗
Via Stocktwits
Wednesday's pre-market session: top gainers and losers ↗
Via Chartmill
Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗
Via Stocktwits
Topics Stocks
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout ↗
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ventyx Provides Clinical and Corporate Updates
From Ventyx Biosciences, Inc.
Via GlobeNewswire
News headline image
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Ventyx Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ventyx Biosciences, Inc. - Common Stock publicly traded?
Yes, Ventyx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ventyx Biosciences, Inc. - Common Stock trade on?
Ventyx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ventyx Biosciences, Inc. - Common Stock?
The ticker symbol for Ventyx Biosciences, Inc. - Common Stock is VTYX on the Nasdaq Stock Market
What is the current price of Ventyx Biosciences, Inc. - Common Stock?
The current price of Ventyx Biosciences, Inc. - Common Stock is 13.93
When was Ventyx Biosciences, Inc. - Common Stock last traded?
The last trade of Ventyx Biosciences, Inc. - Common Stock was at 01/22/26 02:44 PM ET
What is the market capitalization of Ventyx Biosciences, Inc. - Common Stock?
The market capitalization of Ventyx Biosciences, Inc. - Common Stock is 815.70M
How many shares of Ventyx Biosciences, Inc. - Common Stock are outstanding?
Ventyx Biosciences, Inc. - Common Stock has 816M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.